HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
CAT-213
Description
CAT-213 is a fully human anti-eotaxin monoclonal antibody with potential in the treatment of allergic disorders, has moved into pre-clinical development. It is developed by MedImmune for the treatment of Allergic Rhinitis.
No brand information found.
